DAFNA Capital Management LLC
Position in EWTX — Edgewise Therapeutics, Inc.
CIK 1389933
LOS ANGELES, CA
Position in EWTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,215,655
+$5,680,221 QoQ
Shares Held
226,819
+102.1% QoQ
Ownership
0.209%
of shares outstanding
% of Portfolio
1.87%
of 13F equity value
Holder Rank
#53
of 223 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EWTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DAFNA Capital Management LLC holds $345,637,467 across 65 Biotechnology names. EWTX ranks #9 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
562,630 | $105,369,346 | |
| 2 | NKTR |
Nektar Therapeutics
|
318,380 | $22,226,107 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
739,014 | $19,007,440 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
497,240 | $18,532,134 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
250,772 | $15,136,597 | |
| 6 | CYTK |
Cytokinetics Inc
|
171,998 | $14,652,509 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
441,829 | $13,621,588 | |
| 8 | ASND |
Ascendis Pharma A/S
|
48,469 | $12,927,651 |
All Filings in EWTX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,215,655 | 226,819 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,535,434 | 112,236 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,963,848 | 159,736 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,466,797 | 213,736 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,122,015 | 238,140 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,029,080 | 183,140 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,996,638 | 187,140 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,082,811 | 227,906 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,226,447 | 290,197 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,585,033 | 306,197 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,916,260 | 449,384 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,976,070 | 519,384 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,025,226 | 519,384 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,890,704 | 733,239 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,855,576 | 766,843 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,686,142 | 781,112 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,539,833 | 695,959 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,460,475 | 356,750 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||